Median Technologies SA
PAR:ALMDT
Net Margin
Median Technologies SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| FR |
|
Median Technologies SA
PAR:ALMDT
|
88.3m EUR |
-110%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
45.9B USD |
27%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
32.1B AUD |
52%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
11.9B USD |
39%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.6T JPY |
14%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
67.9B SEK |
27%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.1B USD |
9%
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.1B CNY |
3%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
265.1B INR | N/A | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
-4%
|
Median Technologies SA
Glance View
MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Median Technologies SA's most recent financial statements, the company has Net Margin of -110%.
You don't have any saved screeners yet